Even otherwise healthy children can end up in hospital with this winter respiratory virus.
Academic rigor, journalistic flair
Articles on Monoclonal antibody treatment
Displaying all articles
In health care crises, researchers can avoid waiting for clinical trial results by using data from health care systems to analyze the effectiveness of treatments for COVID-19 and other illnesses.
Antiretroviral therapies for HIV, while extremely effective, need to be taken daily for life. Designing antibody treatments that need to be taken only once could improve compliance and reduce drug resistance.
Although Medicare has agreed to pay for Aduhelm, its coverage comes with restrictions.
Top contributors
-
Professor of Pathology, Vice-chair for Research, University of Miami
-
Assistant Professor of Emergency Medicine, Albert Einstein College of Medicine
-
Associate Professor of Medicine, Epidemiology and Clinical and Translational Science, University of Pittsburgh
-
Clinical Assistant Professor of Medicine, University of Pittsburgh
-
Vice President of Clinical Analytics, University of Pittsburgh
-
Research Nurse Coordinator, Murdoch Children's Research Institute
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
-
Paediatric Respiratory Physician, and Honorary Fellow Manager, Murdoch Children's Research Institute
-
Senior Research Officer, Murdoch Children's Research Institute
